Abstract:Background: Mild subclinical hypothyroidism (SCH) affects a large number of people and is known to be a risk factor for dyslipidemia. However, whether mild SCH patients should be treated with L-thyroxine to improve lipid profiles remains controversial. In addition, it is also unclear whether all mild SCH patients can benefit from L-thyroxine treatment, regardless of basal thyrotropin or lipid levels. This study aimed to assess the effects of L-thyroxine replacement therapy on the lipid profiles of mild SCH patients. Methods: This open-label randomized controlled trial was performed in Ningyang County, Shandong Province, China. A total of 378 mild SCH patients with diagnoses confirmed by two thyroid function tests were randomly assigned to either the intervention group (L-thyroxine replacement therapy) or the control group (no treatment). The primary outcome was a change in serum total cholesterol (TC) concentration. Results: In all, 369 participants completed the 15-month follow-up period. Reduced TC concentrations were more prominent in the intervention group than they were in the control group (-0.41mmol/L vs. -0.17 mmol/L; p = 0.012), and changes in low-density lipoprotein cholesterol levels exhibited the same trend. Subgroup analyses were performed to assess the effects of L-thyroxine in patients with different thyrotropin or TC levels. When the study population was stratified according to basal thyrotropin concentration, all patients who had received L-thyroxine showed reduced TC levels (p < 0.001). The treatment was similarly beneficial for all patients, regardless of basal TC level. Even for subjects with TC levels <5.18 mmol/L, serum TC concentrations remained unchanged in the intervention group (p = 0.936) but increased by 0.35 mmol/L in the control group (p = 0.004). Conclusions: The findings suggest that mild SCH patients could benefit from L-thyroxine treatment to improve lipid profiles, regardless of basal thyrotropin or TC concentrations.

Thyrotropin Alters T Cell Development in the Thymus in Subclinical Hypothyroidism Mouse Model.

Thyroid-stimulating Hormone Stimulation Downregulates Autophagy and Promotes Apoptosis in Chondrocytes.

Thyroid-stimulating hormone induces insulin resistance in adipocytes via endoplasmic reticulum stress

Natural History of Mild Subclinical Hypothyroidism in a Middle-Aged and Elderly Chinese Population: a Prospective Study.

A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism.

High Thyroid-Stimulating Hormone Level is Associated with the Risk of Developing Atherosclerosis in Subclinical Hypothyroidism

Long non-coding RNA NEAT1 regulates endothelial functions in subclinical hypothyroidism through miR-126/TRAF7 pathway

Endoplasmic Reticulum Stress May Play a Pivotal Role in Lipid Metabolic Disorders in a Novel Mouse Model of Subclinical Hypothyroidism

Thyroid hormone deprival and TSH/TSHR signaling deficiency lead to central hypothyroidism-associated intestinal dysplasia

Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice

Thyrotropin Receptor Signaling Deficiency Impairs Spatial Learning and Memory in Mice.

Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function

Cholesterol Synthesis Increased in the MMI-Induced Subclinical Hypothyroidism Mice Model

The effects of subclinical hypothyroidism on serum lipid level and TLR4 expression of monocyte in peripheral blood of rats.

Thyrotropin Aggravates Atherosclerosis by Promoting Macrophage Inflammation in Plaques.

Depression-like Behavior in Subclinical Hypothyroidism Rat Induced by Hemi-Thyroid Electrocauterization

SAT-285 TSH/TSHR Signaling Deficiency Impairs Spatial Learning and Memory

The Arrest of T Cell Maturation in Spontaneously Hypertensive Rats with a Deficient Production of Thymic Factors.

Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review).

Abnormal Glucose Metabolism and Insulin Resistance Are Induced Via the IRE1α/XBP-1 Pathway in Subclinical Hypothyroidism

Identification and Functional Characterization of a Novel Thyrotropin Receptor Mutation (V87L) in a Chinese Woman with Subclinical Hypothyroidism.